Serialization Playbook newly revised with updates on new legislation

Download the latest edition of HCP’s Serialization Playbook that will bring you up to date on DQSA/DSCSA, and what it means for your serialization efforts.  Learn More »

Combination products packaging

Articles discuss trends and issues related to packaging combination products, which may combine pharmaceuticals and medical devices, medical devices and biologics, biologics and pharmaceuticals, or various combinations of these, as well as kit packaging. Some examples may include the packaging of stents, vaccines, and two or more regulated products that are combined to produce a single dose or unit.

The European Medicines Agency EMA is a decentralized agency of the European Union, located in London. The agency is responsible
May 22, 2015 | News

EMA revises fixed combination product guideline

Covers clinical development requirements for fixed combination products—open for consultation until Nov. 15, 2015.
E-BOOK SPECIAL REPORT
25 Best Healthcare Package Designs
Sign up to receive timely updates from our editors and download this e-book of our editors’ selections for most innovative healthcare package designs of the past year.
This is a stock image of a medical laboratory facility.
May 18, 2015 | News

Investigative report shines light on medical laboratory errors

Milwaukee Journal Sentinel story cites improperly labeled samples, lack of maintenance on test equipment, and improper refrigeration techniques among the reasons behind incorrect test results that put patients at risk.
HealthPack 2016 will be held March 15-17 at the Astor Crowne Plaza in New Orleans.
May 5, 2015 | Feature Article

Medical device packaging takes center stage at HealthPack

HealthPack 2015 focused on exclusive survey and package design. Meanwhile HealthPack 2016 venue is established.
FDA’s John Barlow “Barr” Weiner speaks to attendees of RAPS’ CGMPs for combination products workshop.
April 24, 2015 | Feature Article

FDA expresses desire to work with industry on CGMPs for combination products

RAPS event allows interaction between FDA and industry, focusing on regulatory matters for manufacturers and developers of combination products.
Rockwell Automation: MES software
April 20, 2015 | Controls Product Brief

Rockwell Automation: MES software

PharmaSuite MES Software is a single track-and-trace system for batch and discrete production.
February 8, 2015 | News

Two companies cited for use of unapproved medical devices

Although unrelated cases, both create worry within the medical community
Sanofi launches Afrezza inhalable insulin for diabetes treatment.
February 4, 2015 | Package Case Study

Sanofi launches Afrezza inhalable insulin for diabetes treatment

Single-dose cartridges and a small, discreet, and easy-to-use inhaler give patients an option to injections to help with glycemic control in adults with diabetes.
3M Drug Delivery Systems: Microneedles
January 30, 2015 | Materials Product Brief

3M Drug Delivery Systems: Microneedles

hMTS is a hollow microneedle device available for clinical trials.
The report notes that the global drug-device combination products market, which was valued at US$66 billion in 2012, will report
January 13, 2015 | News

Asia-Pacific market to lead combination product growth

New report forecasts 7.9% CAGR between 2013 and 2019 for global drug-device combination products market.
Downloadable report analyzes growth factors and restraints for biological drugs from 2014 to 2020, using 2013 as a baseline.
January 1, 2015 | News

Biological drugs market to 2020

Downloadable report analyzes growth factors and restraints for biological drugs from 2014 to 2020, using 2013 as a baseline.

Pages

Newsletters
Don't miss intelligence crucial to your job and business!
Click on any newsletter to view a sample. Enter your email address below to sign up!
GENERAL INTEREST
PACKAGE DESIGN/DEVELOPMENT
HEALTHCARE
PACKAGING MACHINERY
PACK EXPO
FROM SISTER PUBLICATION AUTOMATION WORLD
Each newsletter ranges in frequency from once per month to a few times per month at most.